Seronegative Rheumatoid Arthritis Secondary to Immune Checkpoint Inhibitor in a Renal Cell Carcinoma Patient Encountered in a Rural Community-Based Rheumatology Clinic: A Case Report

Immune checkpoint inhibitors (ICIs) are a widely used class of cancer immunotherapy. Those drugs have improved the treatment of cancer since its introduction in the 2000s. Nivolumab is an ICI that can be used for previously untreated renal cell carcinoma. Immune-related adverse events (irAEs) are a...

Descripción completa

Detalles Bibliográficos
Autores principales: De Camps Martinez, Elmer R, Gonzalez, Camila, Hassan, Hamzah, Hassan, Hafsa, Hassan, Farooq
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401612/
https://www.ncbi.nlm.nih.gov/pubmed/37546101
http://dx.doi.org/10.7759/cureus.41394

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401612/
https://www.ncbi.nlm.nih.gov/pubmed/37546101
http://dx.doi.org/10.7759/cureus.41394

Ejemplares similares